HealthQuill
Eli Lilly and Company will acquire SiteOne Therapeutics, Inc. for $1 billion to get access to an inhibitor that may cure chronic pain without using opioids.
Drugs

FDA updated drug labelling regulations guide (2026)

HQ Team July 21, 2026: Every prescription drug sold in the United States carries labelling that the FDA treats as a legal document,.

Read More
Eli Lilly will invest an additional $450 million to expand its manufacturing capacity at Research Triangle Park facility in North Carolina.
Pharma

The weight-loss drug race just got crowded

Jay Shankar July 21, 2026: Global obesity medicine sales hit $66 billion in 2025 and are on track to reach $92 billion this.

Read More
The prevalence of JN.1, a Covid-19 sub-variant, has risen to 62% in the US on Jan. 5 compared to two weeks prior, according to the National Public Health Agency.
Health Research

Pandemic-born four-year-olds read well but struggle to focus: Study

July18,2026: One in three four-year-olds born during England’s first COVID-19 lockdown is struggling to focus, follow instructions, or manage frustration in the classroom.

Read More
US regulator, the FDA has approved Gilead Sciences, Inc.'s supplemental new drug application for treating chronic hepatitis B virus in paediatric patients six years of age and older.
Drugs Health

Scientists map 641 new schizophrenia genes using “Social Network” for DNA

HQ Team June 24,2026: Scientists have discovered 641 previously unknown genes linked to schizophrenia, using a revolutionary method that maps how genes “talk” to.

Read More
The FDA has warned consumers against the use of fast-act rheum and UA-Block capsules used to treat inflammation and joint pains as it contains substances that raise blood sugar, heart attacks, and stroke.
Drugs

New procedure, GAE, halves knee pain in osteoarthritis patients

HQ Team June 23, 2026: A minimally invasive procedure that blocks the small blood vessels supplying an arthritic knee can reduce pain by.

Read More
India's Glenmark Pharmaceuticals has got the final approval by the USFDA for its generic prochlorperazine maleate tablets, the generic version of compazine of GlaxoSmithKline.
Drugs

Who is buying India’s hospitals and what it means for its 1.4 Billion people?

HQ Team Editor’s Note: The need for this story arose out of discussions on healthcare access difficulties in the developed world. Horror stories.

Read More
Merck's COVID-19 pill does not stop the risk of prevention of the virus spreading to others in a household, the company stated.
Drugs

FDA approves Utebzi, first carbapenem pill for complicated UTIs

HQ Team June 17, 2026: The US Food and Drug Administration has approved Utebzi (tebipenem pivoxil), an antibiotic pill for people suffering from.

Read More
Obesity is a health risk that needs to be tackled worldwide
Drugs Health

Retatrutide trial shows 30% body weight loss, rivalling bariatric surgery results

HQ Team June 17, 2026: Retatrutide, an experimental “triple-agonist” weight-loss drug developed by Eli Lilly, helped patients lose nearly a third of their.

Read More
Indian heat wave
Climate

Heatwaves linked to 26,500 ozone deaths in India in 2024: IIT study

HQ Team June 16, 2026: Heatwaves across India may have intensified ground-level ozone pollution linked to more than 26,500 deaths in 2024, according.

Read More
GSK Plc., a British global pharmaceutical company, announced the FDA had approved an oral drug to treat anaemia arising from chronic kidney disease in patients who have been on dialysis for four months.
Drugs Pharma

FDA expands approval of kidney cancer drug to earlier-stage patients

HQ Team June 16, 2026: The US Food and Drug Administration (FDA) has expanded approval of belzutifan, a first-in-class kidney cancer drug, to.

Read More